When it comes to biotechnology and healthcare, the author of today’s article advises that “While you might think that coronavirus vaccine stocks take the cake… Read More »3 Biotech Stocks To Watch As Other Trends Take The Spotlight Away From COVID
A commercial-stage biopharmaceutical company focused on developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health and a clinical-stage biopharmaceutical company… Read More »Women’s Sexual Health, Oncology & COVID-19: 3 Biotech Penny Stocks To Watch Right Now
The two biotech stocks highlighted in today’s article await big FDA decisions this month – one for an anti-itch drug that could be used in… Read More »Ahead Of Big FDA Decisions On Their Anti-Itch And Anti-Cancer Drugs, Analysts See These 2 Biotech Stocks As Solid Buys
A biopharma company involved in COVID-19 vaccines and an acquisition company for medical technologies comprise the two new biotech stocks to watch highlighted in today’s… Read More »New Stocks To Watch In Biotech, Tech, Cleantech & More
Shares of the two drug makers discussed in today’s article have been beaten down, thanks in large part to an FDA advisory panel vote in… Read More »Are These 2 Beaten-Down Biotechs Buys Before Bouncing Back?
If you want to pick your own biotech stocks, rather than investing in a biotech-focused ETF or mutual fund, the author of today’s article advises… Read More »Biotech Bargains: 4 Names Trading Far Below Their Average Price Targets
The rapid spread of the hyper-contagious Delta variant of the coronavirus, along with the increasing need for treatments for other critical diseases, ensures a continued… Read More »3 Biotech Stocks With Promising Product Pipelines And More Than 170% Near-Term Upside Potential
Against the current backdrop for the biotech industry, comprised of continued efforts to fight COVID-19 as well as a focus on developing treatments for heretofore… Read More »These 2 Biotech Stocks Appear Attractively Cheap And Attractively Positioned For Solid Returns
Looking at the biotech sector right now, new drug approvals could gain momentum in the wake of the FDA’s approval of Biogen’s Alzheimer’s drug, mergers… Read More »3 Outperforming Biotech Stocks With Further Upside In The Back Half Of 2021
The five biotech stocks discussed in today’s article were among the worst performers in the first half of 2021 – but thanks to upcoming catalysts,… Read More »Thanks To Upcoming Catalysts, These Biotech Stocks Could Go From First-Half Losers To Second-Half Winners